Home/Filings/4/0001104659-20-117800
4//SEC Filing

ITRI LORETTTA M 4

Accession 0001104659-20-117800

CIK 0000722830other

Filed

Oct 22, 8:00 PM ET

Accepted

Oct 23, 5:34 PM ET

Size

8.4 KB

Accession

0001104659-20-117800

Insider Transaction Report

Form 4
Period: 2020-10-23
ITRI LORETTTA M
Chief Medical Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2020-10-2315,0000 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-10-23200,0000 total
    Common Stock (200,000 underlying)
Footnotes (2)
  • [F1]In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was automatically cancelled and converted into the right to receive $88.00 in cash (the "Offer Price"), without interest and subject to required withholding taxes.
  • [F2]In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock ("Stock Option") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration.

Documents

1 file

Issuer

IMMUNOMEDICS INC

CIK 0000722830

Entity typeother

Related Parties

1
  • filerCIK 0001137918

Filing Metadata

Form type
4
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 5:34 PM ET
Size
8.4 KB